![Immunai founders Luis Voloch, right, and Noam Solomon, left. Photo: Eric Sultan](https://nocamels.com/wp-content/uploads/2021/02/Immunai-founders-e1613489458559-350x179.jpg)
Israeli-Found Firm Immunai Raises $215M For Its Drug Discovery Platform
The new infusion of capital will be used to expand Immunai’s “drug actuary” platform for target validation and evaluation.
October 28, 2021
![Immunai founders Luis Voloch, right, and Noam Solomon, left. Photo: Eric Sultan](https://nocamels.com/wp-content/uploads/2021/02/Immunai-founders-e1613489458559-350x179.jpg)
Biotech Startup Immunai Raises $60M To Fuel Growth Of Drug Discovery Platform
Founded in 2018, Immunai is on a mission to map out the immune system to improve immunotherapies and discover new treatments.
February 16, 2021